Compare EVO & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | EXPI |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Germany | United States |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | N/A | 2010 |
| Metric | EVO | EXPI |
|---|---|---|
| Price | $2.33 | $5.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $11.50 |
| AVG Volume (30 Days) | 123.2K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,147,681.00 |
| Revenue This Year | N/A | $6.93 |
| Revenue Next Year | $7.13 | $5.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 220.39 |
| 52 Week Low | $2.40 | $5.84 |
| 52 Week High | $4.80 | $12.23 |
| Indicator | EVO | EXPI |
|---|---|---|
| Relative Strength Index (RSI) | 22.34 | 15.41 |
| Support Level | N/A | N/A |
| Resistance Level | $3.78 | $11.36 |
| Average True Range (ATR) | 0.10 | 0.31 |
| MACD | -0.11 | -0.07 |
| Stochastic Oscillator | 0.42 | 2.10 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.